StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.78−0.12 (-3.08%)

Close on Nov 18, 2026Market cap $1.33BP/E –Yield –

Nuvation Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nuvation Bio's price to sales ratio was 8.7× on Nov 11, 2026, against 101.4× a year earlier. Over the last 2 years it ranged from 8.7× to 451.0×, with a median of 69.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.7×−104.4
2025Dec 31, 2025113.2×−300.5
2024Dec 31, 2024413.7×–

More Nuvation Bio figures

See a number that looks wrong?